CAS 7597-18-4 | 6-Nitro-1H-indazole | CAS Number 7597-18-4

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Nitro Compounds > 7597-18-4

7597-18-4 | 6-Nitro-1H-indazole

CAS No: 7597-18-4 Catalog No: AG003NBE MDL No:MFCD00005695

Product Description

Catalog Number:

AG003NBE

Chemical Name:

6-Nitro-1H-indazole

CAS Number:

7597-18-4

Molecular Formula:

C7H5N3O2

Molecular Weight:

163.1335

MDL Number:

MFCD00005695

IUPAC Name:

6-nitro-1H-indazole

InChI:

InChI=1S/C7H5N3O2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4H,(H,8,9)

InChI Key:

ORZRMRUXSPNQQL-UHFFFAOYSA-N

SMILES:

[O-][N+](=O)c1ccc2c(c1)[nH]nc2

EC Number:

231-500-9

Properties

Complexity:

192

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

163.038g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

163.136g/mol

Monoisotopic Mass:

163.038g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

74.5A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

2.1

Literature

Title	Journal
Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).	Free radical research 20091001
Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.	Bioorganic & medicinal chemistry 20090901
Activities of 7-nitroindazole and 1-(2-(trifluoromethylphenyl)-imidazole independent of neuronal nitric-oxide synthase inhibition.	The Journal of pharmacology and experimental therapeutics 20080501
Microsphere-based protease assays and screening application for lethal factor and factor Xa.	Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency.	Biochemistry 20021126